Topotecan (trade name Hycamtin) is a chemotherapeutic agent that is a topoisomerase inhibitor. It is a synthetic, water-soluble analog of the natural chemical compound camptothecin. It is used in the form of its hydrochloride salt to treat ovarian cancer, lung cancer and other cancer types.
In 2018, the global Topotecan market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Topotecan status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Topotecan development in United States, Europe and China.
The key players covered in this study
GSK
Teva
Fresenius Kabi
Cipla
Sagent Pharmaceuticals
Mylan
Pfizer
Dr. Reddy's Laboratories
Market segment by Type, the product can be split into
Capsules
Injection
Market segment by Application, split into
Ovarian Cancer
Lung Cancer
Other Cancer types
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Topotecan status, future forecast, growth opportunity, key market and key players.
To present the Topotecan development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Topotecan are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Topotecan Market Size Growth Rate by Type (2014-2025)
1.4.2 Capsules
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Topotecan Market Share by Application (2014-2025)
1.5.2 Ovarian Cancer
1.5.3 Lung Cancer
1.5.4 Other Cancer types
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Topotecan Market Size
2.2 Topotecan Growth Trends by Regions
2.2.1 Topotecan Market Size by Regions (2014-2025)
2.2.2 Topotecan Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Topotecan Market Size by Manufacturers
3.1.1 Global Topotecan Revenue by Manufacturers (2014-2019)
3.1.2 Global Topotecan Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Topotecan Market Concentration Ratio (CR5 and HHI)
3.2 Topotecan Key Players Head office and Area Served
3.3 Key Players Topotecan Product/Solution/Service
3.4 Date of Enter into Topotecan Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Topotecan Market Size by Type (2014-2019)
4.2 Global Topotecan Market Size by Application (2014-2019)
5 United States
5.1 United States Topotecan Market Size (2014-2019)
5.2 Topotecan Key Players in United States
5.3 United States Topotecan Market Size by Type
5.4 United States Topotecan Market Size by Application
6 Europe
6.1 Europe Topotecan Market Size (2014-2019)
6.2 Topotecan Key Players in Europe
6.3 Europe Topotecan Market Size by Type
6.4 Europe Topotecan Market Size by Application
7 China
7.1 China Topotecan Market Size (2014-2019)
7.2 Topotecan Key Players in China
7.3 China Topotecan Market Size by Type
7.4 China Topotecan Market Size by Application
8 Japan
8.1 Japan Topotecan Market Size (2014-2019)
8.2 Topotecan Key Players in Japan
8.3 Japan Topotecan Market Size by Type
8.4 Japan Topotecan Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Topotecan Market Size (2014-2019)
9.2 Topotecan Key Players in Southeast Asia
9.3 Southeast Asia Topotecan Market Size by Type
9.4 Southeast Asia Topotecan Market Size by Application
10 India
10.1 India Topotecan Market Size (2014-2019)
10.2 Topotecan Key Players in India
10.3 India Topotecan Market Size by Type
10.4 India Topotecan Market Size by Application
11 Central & South America
11.1 Central & South America Topotecan Market Size (2014-2019)
11.2 Topotecan Key Players in Central & South America
11.3 Central & South America Topotecan Market Size by Type
11.4 Central & South America Topotecan Market Size by Application
12 International Players Profiles
12.1 GSK
12.1.1 GSK Company Details
12.1.2 Company Description and Business Overview
12.1.3 Topotecan Introduction
12.1.4 GSK Revenue in Topotecan Business (2014-2019)
12.1.5 GSK Recent Development
12.2 Teva
12.2.1 Teva Company Details
12.2.2 Company Description and Business Overview
12.2.3 Topotecan Introduction
12.2.4 Teva Revenue in Topotecan Business (2014-2019)
12.2.5 Teva Recent Development
12.3 Fresenius Kabi
12.3.1 Fresenius Kabi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Topotecan Introduction
12.3.4 Fresenius Kabi Revenue in Topotecan Business (2014-2019)
12.3.5 Fresenius Kabi Recent Development
12.4 Cipla
12.4.1 Cipla Company Details
12.4.2 Company Description and Business Overview
12.4.3 Topotecan Introduction
12.4.4 Cipla Revenue in Topotecan Business (2014-2019)
12.4.5 Cipla Recent Development
12.5 Sagent Pharmaceuticals
12.5.1 Sagent Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Topotecan Introduction
12.5.4 Sagent Pharmaceuticals Revenue in Topotecan Business (2014-2019)
12.5.5 Sagent Pharmaceuticals Recent Development
12.6 Mylan
12.6.1 Mylan Company Details
12.6.2 Company Description and Business Overview
12.6.3 Topotecan Introduction
12.6.4 Mylan Revenue in Topotecan Business (2014-2019)
12.6.5 Mylan Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Topotecan Introduction
12.7.4 Pfizer Revenue in Topotecan Business (2014-2019)
12.7.5 Pfizer Recent Development
12.8 Dr. Reddy's Laboratories
12.8.1 Dr. Reddy's Laboratories Company Details
12.8.2 Company Description and Business Overview
12.8.3 Topotecan Introduction
12.8.4 Dr. Reddy's Laboratories Revenue in Topotecan Business (2014-2019)
12.8.5 Dr. Reddy's Laboratories Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
